Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Myron A. Waclawiw"'
Autor:
Pamela S. Douglas, Kathleen V. Fitch, Heather J. Ribaudo, Karin L. Klingman, Myron A. Waclawiw, Laura M. Smeaton, Beverly Alston-Smith, Melissa L Murry, Emma M Kileel, Katharine Cooper-Arnold, Markella V. Zanni, Shashi Sangle, Edward M. Gardner, Steven K. Grinspoon, Patrice Desvigne-Nickens, José Valdez Madruga, Beatriz Grinsztejn, Kate Starr
Publikováno v:
J Infect Dis
Because persons who identify across the transgender spectrum (PATS) are a key population in human immunodeficiency virus (HIV) yet are underreported in HIV and cardiovascular research, we aimed to characterize this population within the REPRIEVE glob
Autor:
Carl J. Fichtenbaum, Markella V. Zanni, Craig A. Sponseller, Michael T. Lu, Steven K. Grinspoon, Judith A. Aberg, Pamela S. Douglas, Katharine Cooper-Arnold, Myron A. Waclawiw, Beverly Alston-Smith, Heather J. Ribaudo, Karin L. Klingman, Carlos Malvestutto, Udo Hoffmann, Judith S. Currier, Kathleen V. Fitch, Patrice Desvigne-Nickens, Edgar T. Overton
Publikováno v:
Am Heart J
Cardiovascular disease (CVD) is more frequent among people with HIV (PWH) and may relate to traditional and nontraditional factors, including inflammation and immune activation. A critical need exists to develop effective strategies to prevent CVD in
Autor:
Pamela S. Douglas, Beverly Alston-Smith, Myron A. Waclawiw, Udo Hoffmann, Markella V. Zanni, Michael T. Lu, John Sukumar Aluru, Patrice Desvigne-Nickens, Devvora Olalere, Steven K. Grinspoon, Heather J. Ribaudo, Karin L. Klingman, Elizabeth C. Adami, Saeyun Lee, Tricia H. Burdo, Reprieve Investigators, Katharine Cooper-Arnold, Kathleen V. Fitch, Nadja Arifovic, Judith A. Aberg, Alexander R. Ivanov, Edgar T. Overton, Kenneth C. Williams, Carl J. Fichtenbaum, Michael T. Osborne
Publikováno v:
Am Heart J
Background People with HIV (PWH) have increased cardiovascular events, inflammation, and high-risk coronary atherosclerosis. Statin therapy has been shown to lower the risk of cardiovascular disease (CVD) in the general population, but whether this r
Autor:
James G. Taylor, Gwenyth R. Wallen, Meghan Quinn, Cassie Seamon, Katherine Roskom, Myron A. Waclawiw, Deepika S. Darbari, Lena Diaw, Kathleen Vaughan, Anna Conrey, Inna Belfer, Jennifer A. Haythornthwaite, Alan N. Schechter
Publikováno v:
Scandinavian Journal of Pain. 17:279-286
Pain is the hallmark of sickle cell anemia (SCA), presenting as recurrent acute events or chronic pain. Central sensitization, or enhanced excitability of the central nervous system, alters pain processing and contributes to the maintenance of chroni
Autor:
Alan N. Schechter, Andrew E. Arai, Jonathan R. Lindner, Gregory J. Kato, Vandana Sachdev, Stanislav Sidenko, Myron A. Waclawiw, Hwaida Hannoush, Melinda D. Wu, Cynthia L. Brenneman, Caterina P. Minniti
Publikováno v:
British Journal of Haematology. 179:648-656
Summary In sickle cell disease (SCD), abnormal microvascular function combined with chronic anaemia predisposes patients to perfusion-demand mismatch. We hypothesized that skeletal muscle and myocardial perfusion, normalized to the degree of anaemia,
Autor:
Steven D. Gore, Eric Padron, Amy E. DeZern, Donnie Hebert, James M. Foran, Steven H. Kroft, Myron A. Waclawiw, Alexandra M. Harrington, Jane Jijun Liu, Wael Saber, Steffanie H. Wilson, Jason Walker, Tareq Al Baghdadi, Daniel T. Starczynowski, Johannes B. Goll, Edward J. Gorak, Ling Zhang, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, H. Joachim Deeg, Rafael Bejar, Nancy L. DiFronzo, R. Coleman Lindsley, Rami S. Komrokji, Robert S. Fulton, Harrison Reed, Benjamin L. Ebert, Travis L. Jensen, Gregory A. Abel, Matthew J. Walter
Publikováno v:
Blood. 136:32-33
Introduction: The NHLBI National MDS Study (NCT02775383) is a prospective cohort study conducted at 92 community hospitals and 29 academic centers. It enrolls patients undergoing work up for suspected MDS to understand the genetic, epigenetic, and bi
Autor:
Gregory A. Abel, Steven D. Gore, Jason B. Thompson, Dana E. Rollison, Donnie Hebert, Steffanie H. Wilson, Wael Saber, Cecilia Lee, Myron A. Waclawiw, Nancy L. DiFronzo, James M. Foran, Mikkael A. Sekeres, Eric Padron
Publikováno v:
Blood. 136:15-16
Introduction: Patient-reported outcomes (PROs) such as quality of life (QOL) are variably affected in patients with myelodysplastic syndromes (MDS), but the heterogeneous composition of disease states grouped together as "MDS" increases the difficult
Autor:
Allan Doctor, Philip C. Spinella, Anne F. Eder, Pablo Cure, Stella T. Chou, Shimian Zou, Simon J. Stanworth, Myron A. Waclawiw, Marie E. Steiner, Naomi L.C. Luban, Martha Sola-Visner, Nahed El Kassar, Catherine Levy, William J. Savage, Jeanne E. Hendrickson, Alan E. Mast, Traci Heath Mondoro, Cassandra D. Josephson, Simone A. Glynn, Melania M. Bembea
Publikováno v:
Transfusion. 57:1568-1581
Publikováno v:
Wiley StatsRef: Statistics Reference
Autor:
Donald M. Stablein, Amy E. DeZern, Rami S. Komrokji, Myron A. Waclawiw, Steven D. Gore, Gregory A. Abel, Pearlie K. Epling-Burnette, James M. Foran, Edward J. Gorak, Dana E. Rollison, H. Joachim Deeg, Jesse D. Troy, Matthew J. Walter, Lynn C. Moscinski, James R. Cerhan, Daniel T. Starczynowski, Tareq Al Baghdadi, John W. Thomas, Jane Jijun Liu, Mikkael A. Sekeres, Rafael Bejar, Nancy L. DiFronzo
Publikováno v:
Leukemialymphoma. 60(13)
Myelodysplastic syndromes (MDS), a spectrum of heterogeneous hematopoietic stem cell diseases, vary in clinical severity, response to therapy, and propensity toward progression to acute myeloid leukemia. These are acquired clonal disorders resulting